These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 892912)

  • 41. Mucosal immunisation with Clostridium botulinum type C 16 S toxoid and its non-toxic component.
    Mahmut N; Inoue K; Fujinaga Y; Arimitsu H; Sakaguchi Y; Hughes L; Hirst R; Murphy T; Tsuji T; Watanabe T; Ohyama T; Karasawa T; Nakamura S; Yokota K; Oguma K
    J Med Microbiol; 2002 Oct; 51(10):813-820. PubMed ID: 12435059
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Characterization and reconstitution of functional hemagglutinin of the Clostridium botulinum type C progenitor toxin.
    Kouguchi H; Watanabe T; Sagane Y; Ohyama T
    Eur J Biochem; 2001 Jul; 268(14):4019-26. PubMed ID: 11453996
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nicking of single chain Clostridium botulinum type A neurotoxin by an endogenous protease.
    Dekleva ML; DasGupta BR
    Biochem Biophys Res Commun; 1989 Jul; 162(2):767-72. PubMed ID: 2667520
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intestinal absorption of botulinum toxins of different molecular sizes in rats.
    Sugii S; Ohishi I; Sakaguchi G
    Infect Immun; 1977 Sep; 17(3):491-6. PubMed ID: 903173
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antigenic similarity of toxins produced by Clostridium botulinum type C and D strains.
    Oguma K; Syuto B; Iida H; Kubo S
    Infect Immun; 1980 Dec; 30(3):656-60. PubMed ID: 6785231
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of Clostridium botulinum toxins type D and C1 in molecular property, antigenicity and binding ability to rat-brain synaptosomes.
    Murayama S; Syuto B; Oguma K; Iida H; Kubo S
    Eur J Biochem; 1984 Aug; 142(3):487-92. PubMed ID: 6468375
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Detection of Clostridium botulinum type B toxin in the presence of a lethal substance interfering with toxin neutralization.
    Dezfulian M; Bartlett JG
    Diagn Microbiol Infect Dis; 1985 Mar; 3(2):105-12. PubMed ID: 3884243
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characterization of Hemagglutinin Negative Botulinum Progenitor Toxins.
    Kalb SR; Baudys J; Smith TJ; Smith LA; Barr JR
    Toxins (Basel); 2017 Jun; 9(6):. PubMed ID: 28617306
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Purification and some properties of a lethal toxic fragment of staphylococcal alpha-toxin by tryptic digestion.
    Watanabe M; Kato I
    Biochim Biophys Acta; 1978 Aug; 535(2):388-400. PubMed ID: 678558
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The relation between toxicity and toxin-related-antigen contents of Clostridium botulinum types C and D cultures as determined by mouse bioassay and ELISA.
    Notermans S; Dufrenne J; Kozaki S
    Jpn J Med Sci Biol; 1982; 35(5-6):203-11. PubMed ID: 6761472
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Rapid method for purification of Clostridium botulinuh type C neurotoxin by High Performance Liquid Chromatography (HPLC ).
    Matsuda M; Ozutsumi K; Pei-Ying D; Sugimoto N
    Eur J Epidemiol; 1986 Dec; 2(4):265-271. PubMed ID: 29464575
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Homogeneity and heterogeneity of toxins produced by Clostridium botulinum type C and D strains.
    Oguma K; Syuto B; Agui T; Iida H; Kubo S
    Infect Immun; 1981 Nov; 34(2):382-8. PubMed ID: 6171518
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Enzyme-linked immunosorbent assay for detection of Clostridium botulinum type E toxin.
    Notermans S; Dufrenne J; Kozaki S
    Appl Environ Microbiol; 1979 Jun; 37(6):1173-5. PubMed ID: 384908
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A PCR approach to determine the distribution of toxin genes in closely related Clostridium species: Clostridium botulinum type C and D neurotoxins and C2 toxin, and Clostridium novyi alpha toxin.
    Heffron A; Poxton IR
    J Med Microbiol; 2007 Feb; 56(Pt 2):196-201. PubMed ID: 17244800
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Complete DNA sequences of the botulinum neurotoxin complex of Clostridium botulinum type A-Hall (Allergan) strain.
    Zhang L; Lin WJ; Li S; Aoki KR
    Gene; 2003 Oct; 315():21-32. PubMed ID: 14557061
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Similarity in nucleotide sequence of the gene encoding nontoxic component of botulinum toxin produced by toxigenic Clostridium butyricum strain BL6340 and Clostridium botulinum type E strain Mashike.
    Fujii N; Kimura K; Yokosawa N; Oguma K; Yashiki T; Takeshi K; Ohyama T; Isogai E; Isogai H
    Microbiol Immunol; 1993; 37(5):395-8. PubMed ID: 8355622
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The complete nucleotide sequence of the gene coding for the nontoxic-nonhemagglutinin component of Clostridium botulinum type C progenitor toxin.
    Tsuzuki K; Kimura K; Fujii N; Yokosawa N; Oguma K
    Biochem Biophys Res Commun; 1992 Mar; 183(3):1273-9. PubMed ID: 1567404
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Expression and stability of the nontoxic component of the botulinum toxin complex.
    Miyata K; Yoneyama T; Suzuki T; Kouguchi H; Inui K; Niwa K; Watanabe T; Ohyama T
    Biochem Biophys Res Commun; 2009 Jun; 384(1):126-30. PubMed ID: 19394306
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Correlation between oral toxicity and in vitro stability of Clostridium botulinum type A and B toxins of different molecular sizes.
    Sugii S; Ohishi I; Sakaguchi G
    Infect Immun; 1977 Jun; 16(3):910-4. PubMed ID: 19355
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Responses of Clostridium botulinum type B and E progenitor toxins to some clostridial sulfhydryl-dependent proteases.
    Oishi I; Okada T; Sakaguchi G
    Jpn J Med Sci Biol; 1975 Jun; 28(3):157-64. PubMed ID: 1104932
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.